
Network News

After a pilot last year, GeneNovate, Germany’s first national entrepreneurship program for gene and cell therapies, took place for the second time. All participants in the program met in Berlin on 26 June for the joint closing event. There, they presented a total of 23 research projects to a high-caliber jury of business angels, venture […]
read more
New Publication from Hummingbird Diagnostics GmbH: Early detection of Alzheimer’s disease using small RNAs. Results from the EPAD cohort
Alzheimer’s disease is the most common type of dementia, and early detection is important for better treatment. This study looked at small RNA molecules in the blood to see if they could help identify early signs of Alzheimer’s, especially in people with high levels of amyloid, a key Alzheimer’s marker. Researchers analyzed blood samples from […]
read more
Medicine in the digital age: “MEDI:CUS” cloud for optimal healthcare
Data can save lives. However, in order for health data to be used for the benefit of patients, relevant data must be made available where it is needed. With the MEDI:CUS project, which is funded under the umbrella of the Forum Gesundheitsstandort Baden-Württemberg, the state of Baden-Württemberg is building a secure and data protection-compliant cloud-based […]
read more
AbbVie to Acquire Capstan Therapeutics, Further Strengthening Commitment to Transforming Patient Care in Immunology
NORTH CHICAGO, Ill. and SAN DIEGO, June 30, 2025 /PRNewswire/ — AbbVie (NYSE: ABBV) and Capstan Therapeutics, Inc. (“Capstan”), a clinical-stage biotechnology company dedicated to advancing in vivo engineering of cells through RNA delivery using tLNPs, today announced a definitive agreement under which AbbVie will acquire Capstan, including CPTX2309, a potential first-in-class in vivo tLNP anti-CD19 CAR-T therapy candidate, currently in Phase 1, in […]
read more
Europe’s top health start-ups take centre stage: EIT Health Catapult winners are revealed at HLTH Europe
The EIT Health Catapult 9th Edition competition winners were announced on 17 June at HLTH Europe 2025, the conference where global expertise meets local insight to address Europe’s unique healthcare challenges and opportunities. Previous edition winners and finalists have attracted significant interest from leading Life Sciences and HealthTech companies. EIT Health celebrated the next wave of health […]
read more
Parkinson’s disease: gut microbiome reveals environmental chemical footprints
New meta-analysis uses machine learning tools to explore links between the gut microbiome and Parkinson’s disease Summary Parkinson’s disease is a progressive and common neurodegenerative condition, typically characterised by involuntary shaking, stiffness, and slow movement. Beyond these motor symptoms, individuals often experience a range of non-motor issues, including significant gut problems such as constipation, inflammation, […]
read more
ERC ADVANCED GRANT VALUABLE FUNDING FOR FIVE RESEARCHERS AT UNIVERSITÄT HEIDELBERG
THE EUROPEAN RESEARCH COUNCIL FINANCES GROUNDBREAKING PROJECTS WITH ERC ADVANCED GRANTS Five scientists from Heidelberg University are each receiving valuable funding from the European Research Council (ERC), an ERC Advanced Grant. These grants are intended for top-flight researchers who are pursuing groundbreaking projects with their work. Two of the grants go to Prof. Dr Loredana […]
read more
Hector Foundation Prize 2025 for Annika Reinke: “Metrics Reloaded” improves the quality of AI-supported image analysis
Computer scientist Annika Reinke from the German Cancer Research Center (DKFZ) has been awarded the Hector Foundation Prize 2025, endowed with €10,000, for her outstanding work in the field of AI-supported medical image analysis. She received the award for the project Metrics Reloaded, which can significantly improve the quality and reliability of AI-supported image analysis. […]
read more
Novel laboratory models pave the way for targeted therapies for childhood sarcomas
Sarcomas in soft tissue usually occur in young people and are particularly difficult to treat. Due to a lack of laboratory models, the causes of their development are still poorly understood. A team of researchers from the Hopp Children’s Cancer Centre Heidelberg (KiTZ), the German Cancer Research Centre (DKFZ) and Heidelberg University Hospital (UKHD) has […]
read more